Skytrofa 13.3 mg Powder and solvent for solution for injection

Licence status
Authorised: 11/01/2022
Active substances
Lonapegsomatropin, Somatropin
Dosage Form
Powder and solvent for solution for injection
Licence number
EU/1/21/1607/009
Licence holder
Ascendis Pharma Endocrinology Division A/S

Product documents

Licence information

ATC code
H01AC09 lonapegsomatropin
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
11/01/2022